Literature DB >> 30993429

Authors' response to the letter: Takotsubo syndrome: a neurocardiac syndrome inside the autonomic nervous system.

Sonia Borodzicz1,2, Katarzyna Czarzasta1, Grzegorz Opolski2, Agnieszka Cudnoch-Jędrzejewska3.   

Abstract

Entities:  

Keywords:  Autonomic nervous system; Pathophysiology; Sympathetic nervous system; Takotsubo syndrome

Year:  2019        PMID: 30993429      PMCID: PMC6697712          DOI: 10.1007/s10741-019-09789-y

Source DB:  PubMed          Journal:  Heart Fail Rev        ISSN: 1382-4147            Impact factor:   4.214


× No keyword cloud information.
We appreciate Dr. Marafioti and Dr. Benfari’s interest and comments concerning our article [1]. Referring to their first raised issue, currently, there is little known about the specific neuronal changes in patients with Takotsubo syndrome (TTS). The neuroimaging studies by Klein et al. performed in patients with a history of TTS revealed structural and functional changes not only in structures involved in modulation of the sympathetic nervous system (supplementary motor area, left paracentral gyrus, left superior parietal lobe, putamen, and hippocampus), but also with the regions regulating activation of the parasympathetic nervous system (right precentral gyrus, precuneus, and medial temporal gyrus) [2]. Moreover, the alterations in brain structures regulating both sympathetic and parasympathetic nervous systems, including the left amygdala, angular gyrus and left insula, were observed [2]. It has been suggested that insula mediated the impairment of the baroreflex control observed in TTS, what may play a pivotal role in the pathogenesis of the disease [2, 3]. Another interesting observation in the context of the role of the insular cortex in autonomic regulation may be a report by Yoshimura et al., in which they showed that in the majority of patients with TTS induced by acute ischemic stroke, the culprit infarcts were localized within the insular cortex [4]. So far, there is no clear data on exactly what type of dysfunction of the autonomic nervous system with the distinction of specific structures underlie TTS, and this issue needs to be further determined. Discussing the second mentioned point we agree, that anatomical variability of the sympathetic innervation of the heart may be one of the hypotheses explaining various variants of left ventricular wall motion abnormalities in TTS. As we mentioned in our review article, the study performed by Zaroff et al. showed that some of the wall motion patterns in patients with subarachnoid hemorrhage–induced left ventricular systolic dysfunction were related to the distribution of the myocardial sympathetic nerve terminals [1, 5]. Since the exact anatomy of the sympathetic innervation of the heart in different types of TTS has not yet been determined, it seems to be an interesting direction of research aimed at understanding the causes of observed variations.
  4 in total

1.  Regional patterns of left ventricular systolic dysfunction after subarachnoid hemorrhage: evidence for neurally mediated cardiac injury.

Authors:  J G Zaroff; G A Rordorf; C S Ogilvy; M H Picard
Journal:  J Am Soc Echocardiogr       Date:  2000-08       Impact factor: 5.251

2.  Takotsubo cardiomyopathy in acute ischemic stroke.

Authors:  Sohei Yoshimura; Kazunori Toyoda; Tomoyuki Ohara; Hikaru Nagasawa; Noriko Ohtani; Takahiro Kuwashiro; Hiroaki Naritomi; Kazuo Minematsu
Journal:  Ann Neurol       Date:  2008-11       Impact factor: 10.422

3.  Takotsubo Syndrome - Predictable from brain imaging data.

Authors:  Carina Klein; Thierry Hiestand; Jelena-Rima Ghadri; Christian Templin; Lutz Jäncke; Jürgen Hänggi
Journal:  Sci Rep       Date:  2017-07-14       Impact factor: 4.379

4.  Direct evidences for sympathetic hyperactivity and baroreflex impairment in Tako Tsubo cardiopathy.

Authors:  Angelica Vaccaro; Fabien Despas; Clement Delmas; Olivier Lairez; Elisabeth Lambert; Gavin Lambert; Marc Labrunee; Thibaut Guiraud; Murray Esler; Michel Galinier; Jean Michel Senard; Atul Pathak
Journal:  PLoS One       Date:  2014-03-25       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.